We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
CMP and FDA has granted final approval of the company’s New Drug Application (NDA) for CaroSpir.The dosing inconsistencies of compounded liquids have long been a persistent challenge for physicians.